Breast Cancer

From bras and breastfeeding to lump anxiety and radiation fears, doctors break down the myths that stop men and women alike from getting timely breast cancer screening

Can young women or men get breast cancer? Are mammograms unsafe? In this episode of our fact-check series, doctors debunk the biggest breast health myths and explain why regular screening saves lives.

Why do myths, modesty and misinformation still overshadow one of medicine's best defences against breast cancer? Experts say it is time to make mammograms as routine as blood pressure checks

Breast cancer affects men too, yet most don't know the symptoms. Experts explain warning signs, risks, and why awareness matters

Breast cancer is rising among women under 40, with aggressive subtypes becoming more common. Experts urge early awareness, genetic testing, and regular breast self-exams

Breast cancer awareness: Simple, safe and empowering, regular breast self-exams help you stay one step ahead of potential changes that could signal a cancer risk

Breast cancer awareness: Inherited risk explains only a fraction of breast cancer cases. Regular exercise, balanced nutrition and stress control help protect women's health and support prevention

Women's cancers like breast, cervical, and ovarian are often detected late in poorer countries, sharply reducing survival chances, according to a global Lancet study

Scientists find that high-fat diets and elevated lipid levels can accelerate breast cancer growth, prompting caution over keto regimens among patients and survivors

Researchers have developed an AI model that not only detects breast cancer with near-perfect accuracy but also visually explains its diagnosis to doctors, improving trust and transparency in screening

Breast cancer awareness month 2025: Cases of invasive lobular carcinoma are increasing nearly three times faster than other breast cancers, raising alarm over detection, diagnosis, and treatment gaps

Alkem Laboratories on Monday said it has launched a biosimilar product in India for the treatment of breast cancer. The company has introduced Pertuza injection 420mg/14mL, a pertuzumab biosimilar, for the treatment of HER2-positive breast cancer, the drug firm said in a statement. Alkem's Pertuza is an affordable, indigenously-developed and manufactured biosimilar of pertuzumab, it added. "Oncology is a priority area for Alkem, and our efforts are focused on developing treatment options that combine scientific excellence with wider access. The launch of Pertuza reflects this commitment and further strengthens our oncology portfolio," Alkem CEO Vikas Gupta said. Shares of the company on Monday ended 0.69 per cent down at Rs 5,496 apiece on BSE.

Just one bout of high-intensity or resistance training can cut breast cancer cell growth by up to 30 per cent by boosting anti-cancer proteins, say researchers

Content creator Hallie Swanson felt perfectly healthy-until a routine scan detected Stage 0 breast cancer, highlighting the life-saving power of early screenings even without symptoms

Why does breast cancer spread? Researchers trace the answer to mitochondria, where glutathione import activates survival signals that drive deadly metastasis

Researchers at IIT Guwahati and IASST have designed a novel compound showing promise against aggressive triple-negative breast cancer

A new study reveals that respiratory infections like common flu and coronavirus can awaken dormant breast cancer cells in the lungs, raising concerns for survivors

From age guidelines to radiation concerns and comfort upgrades, here's a full guide to understanding mammography and why it matters for early breast cancer detection

Women living in hotter regions face higher rates of breast, ovarian, cervical and uterine cancers, with heat-linked deaths also on the rise, study shows

With a study showing that only 1.3 per cent of Indian women aged 45 and above undergo screening for breast cancer, experts have called for immediate policy interventions, awareness campaigns and infrastructural advancements to encourage more women to opt for testing. A study published in the BMC Public Health indicate that India's breast cancer screening rates are among the lowest globally. While countries like the US and several European nations boast of screening rates above 80 per cent, India lags even behind some African nations, where 4.5 per cent of women undergo mammograms. Kerala leads with the highest screening rate in India at 4.5 per cent, followed by Karnataka (2.9 per cent) and Maharashtra (2.05 per cent), while Delhi records a shockingly low rate of less than 1 per cent. Experts attributed these abysmal statistics to multiple factors, including lack of awareness, social stigma, poor accessibility, and widespread misconceptions about mammography. Many women in India a